Clinical Trial: Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: The Effect of Autologous Bone Marrow Mononuclear Cell Transplantation on Motor Neuron Disease/Amyotrophic Lateral Sclerosis

Brief Summary: The effect of autologous bone marrow mononuclear cells on Motor Neuron Disease/Amyotrophic Lateral Sclerosis patients.

Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute

Current Primary Outcome: Amyotrophic Lateral Sclerosis Functional rating scale-revised [ Time Frame: 2 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Neurogen Brain and Spine Institute

Dates:
Date Received: September 12, 2014
Date Started: December 2008
Date Completion:
Last Updated: September 23, 2016
Last Verified: September 2016